Skip to content
value.today

CDx, Inc.

🇺🇸 La Jolla, California, USAHealth CareFounded 2013
Total raised
$14 M
2 rounds on record
Latest round
$7 M
Feb 2015
First round on record
Feb 2014
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of CDx, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2015$7 MNo. 2$2 to $10 million

CDx, Inc.: Raise no. 2, Feb 2015

Investors in this round

105 investors had bought by the notice of Mar 9, 2015: 105 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $8 M offered; $1 M still to sell
Smallest investment taken
$1
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$684,250
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Yazbeck · Executive Officer, Director
  • Samuel Sanzeri · Executive Officer
  • Thomas Gruber · Executive Officer, Director
  • Stephen Katz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Paulson Investment Company LLC (CRD 5670) · Portland, OregonSold in all US states

Remarks in the notice

  • On the amounts: “Total Offering Amount: $7,999,999.70 Total Amount Sold: $6,917,808.70 Total Remaining to be Sold: $1,082,191.00”

Signed by Daniel Yazbeck, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 9, 2015. Read the notice at the SEC.

equity, optionsSEC
Feb 2014$7 MNo. 1$2 to $10 million

CDx, Inc.: Raise no. 1, Feb 2014

Investors in this round

105 investors had bought by the notice of Mar 6, 2015: 105 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $8 M offered; $1 M still to sell
Smallest investment taken
$1
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$684,250
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Yazbeck · Executive Officer, Director
  • Samuel Sanzeri · Executive Officer
  • Thomas Gruber · Executive Officer, Director
  • Stephen Katz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Paulson Investment Company LLC (CRD 5670) · Portland, OregonSold in all US states

Remarks in the notice

  • On the amounts: “Total Offering Amount: $7,999,999.70 Total Amount Sold: $6,917,808.70 Total Remaining to be Sold: $1,082,191.00”

Signed by Daniel Yazbeck, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 6, 2015. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • CDx, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2015).

    SEC Form D · Mar 2015

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Mar 2015

That is all the official record says: CDx, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of CDx, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 105 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by CDx, Inc.
NameRoleNamed in
Daniel YazbeckExecutive officerMar 2015
Samuel SanzeriExecutive officerMar 2015
Thomas GruberExecutive officerMar 2015
Daniel YazbeckDirectorMar 2015
Stephen KatzDirectorMar 2015
Thomas GruberDirectorMar 2015